249 related articles for article (PubMed ID: 18983762)
1. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.
Griffiths P; Whitley R; Snydman DR; Singh N; Boeckh M;
Herpes; 2008 Oct; 15(1):4-12. PubMed ID: 18983762
[TBL] [Abstract][Full Text] [Related]
2. Management of CMV infection and disease in transplant patients. 27-29 February 2004.
Razonable RR; Emery VC;
Herpes; 2004 Dec; 11(3):77-86. PubMed ID: 15960905
[TBL] [Abstract][Full Text] [Related]
3. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones C; Craig JC
Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954
[TBL] [Abstract][Full Text] [Related]
4. The case for cytomegalovirus prophylaxis in solid organ transplantation.
Snydman DR
Rev Med Virol; 2006; 16(5):289-95. PubMed ID: 16888821
[TBL] [Abstract][Full Text] [Related]
5. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones CJ; Craig JC
Cochrane Database Syst Rev; 2006 Jan; (1):CD005133. PubMed ID: 16437521
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus risk, prevention, and management in pediatric solid organ transplantation.
Martin JM; Danziger-Isakov LA
Pediatr Transplant; 2011 May; 15(3):229-36. PubMed ID: 21199215
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
Singh N
J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
[TBL] [Abstract][Full Text] [Related]
8. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.
Legendre C; Pascual M
Clin Infect Dis; 2008 Mar; 46(5):732-40. PubMed ID: 18220478
[TBL] [Abstract][Full Text] [Related]
9. Assessing the economic merits of managing cytomegalovirus infection in organ and stem cell transplantation.
Wait S; Musingarimi P; Briggs A; Tillotson G
J Med Econ; 2009 Mar; 12(1):68-76. PubMed ID: 19450067
[TBL] [Abstract][Full Text] [Related]
10. Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant.
Prentice HG; Kho P
Bone Marrow Transplant; 1997 Jan; 19(2):135-42. PubMed ID: 9116610
[TBL] [Abstract][Full Text] [Related]
11. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.
Owers DS; Webster AC; Strippoli GF; Kable K; Hodson EM
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005133. PubMed ID: 23450558
[TBL] [Abstract][Full Text] [Related]
12. Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies.
Small LN; Lau J; Snydman DR
Clin Infect Dis; 2006 Oct; 43(7):869-80. PubMed ID: 16941368
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
Puius YA; Snydman DR
Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
[TBL] [Abstract][Full Text] [Related]
14. Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients.
Verkruyse LA; Storch GA; Devine SM; Dipersio JF; Vij R
Bone Marrow Transplant; 2006 Jan; 37(1):51-6. PubMed ID: 16284613
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
Steininger C
Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
[TBL] [Abstract][Full Text] [Related]
16. Special considerations regarding CMV in lung transplantation.
Avery RK
Transpl Infect Dis; 1999; 1 Suppl 1():13-8. PubMed ID: 11565581
[TBL] [Abstract][Full Text] [Related]
17. [Prophylaxis against cytomegalovirus infection in pediatric and adult patients undergoing solid organ and hematopoietic stem cells transplantation].
Ferrés M; Nervi B; Ramírez P
Rev Chilena Infectol; 2012 Sep; 29 Suppl 1():S23-8. PubMed ID: 23282552
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of CMV infection after stem cell transplantation.
Hebart H; Einsele H
Hum Immunol; 2004 May; 65(5):432-6. PubMed ID: 15172442
[TBL] [Abstract][Full Text] [Related]
19. [Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology].
Cornella C; Torazza MC; Strippoli GF; Segoloni G;
G Ital Nefrol; 2007; 24 Suppl 37():S165-78. PubMed ID: 17347963
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
Fisher RA
Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
